patient suffered a heart attack 3 weeks ago on 7FEB2022/ suffered a second Heart Attack on 24FEB2021; being very fatigued October, November, December, and January; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (patient suffered a heart attack 3 weeks ago on 7FEB2022/ suffered a second Heart Attack on 24FEB2021) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type 2 diabetes mellitus.   On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced FATIGUE (being very fatigued October, November, December, and January). On 07-Feb-2022, the patient experienced MYOCARDIAL INFARCTION (patient suffered a heart attack 3 weeks ago on 7FEB2022/ suffered a second Heart Attack on 24FEB2021) (seriousness criterion medically significant). The patient was treated with Surgery (ablation on Thursday Feb 10, 2022,also had balloon angioplasty and two cardiac stents on Feb 24 2022) for Myocardial infarction. At the time of the report, MYOCARDIAL INFARCTION (patient suffered a heart attack 3 weeks ago on 7FEB2022/ suffered a second Heart Attack on 24FEB2021) and FATIGUE (being very fatigued October, November, December, and January) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, Blood glucose: blood glucose of 456 after the first heart attack (High) Blood Glucose of 456 after the first heart attack. On 24-Feb-2022, Blood glucose: 438 (High) 438. On an unknown date, Blood glucose: blood sugar has been very high in the 300 to 400 r (High) blood sugar has been very high in the 300 to 400 range..         The patient reported no adverse reactions or side effects after first dose. Patient had heart attack twice in Feb-2022. No concomitant medication details was provided. No treatment medication details was provided. COMPANY COMMENT : This spontaneous case concerns a 70-year-old, male patient with relevant medical history of Type 2 diabetic, who experienced unexpected serious (seriousness criterion medically significant) AESI event of myocardial infraction (reported as patient suffered a heart attack 3 weeks ago on 7FEB2022/ suffered a second Heart Attack on 24FEB2021), first heart attack occurred on 7months 27 days and second heart attack occurred on 8 months 13 days after second dose of mRNA-1273 vaccine. It was reported that Ablation was done on February,10, 2022 and balloon angioplasty two cardiac stents was done ON 24 FEB 2022. In February 2022, Blood glucose was 456 after the first heart attack on February 2022, Blood glucose is 438 on 24-Feb-2022. Medical history of Type 2 diabetic remains as confounding. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 70-year-old, male patient with relevant medical history of Type 2 diabetic, who experienced unexpected serious (seriousness criterion medically significant) AESI event of myocardial infraction (reported as patient suffered a heart attack 3 weeks ago on 7FEB2022/ suffered a second Heart Attack on 24FEB2021), first heart attack occurred on 7months 27 days and second heart attack occurred on 8 months 13 days after second dose of mRNA-1273 vaccine. It was reported that Ablation was done on February,10, 2022 and balloon angioplasty two cardiac stents was done ON 24 FEB 2022. In February 2022, Blood glucose was 456 after the first heart attack on February 2022, Blood glucose is 438 on 24-Feb-2022. Medical history of Type 2 diabetic remains as confounding. The benefit-risk relationship of mRNA-1273 is not affected by this report.